Recruitment of patients with lung cancer into a randomised clinical trial: Experience at two centres

Thorax

Volumn 55, Issue 6, 2000, Pages 463-465

  Spiro, S G ^a   Gower, N H ^a,b   Evans, M T ^b   Facchini, F M ^a   Rudd, R M ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Lung cancer; Patient recruitment; Randomised controlled trials

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION;

EID: 0034108034     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.6.463     Document Type: Article

References (14)

1. 1 Stephens R, Gibson D. The impact of clinical trials on the treatment of lung cancer. Clin Oncol 1993;5:211-9.
2. 2 Twelves CJ, Thomson CS, Young J, et al. Entry into clinical trials in breast cancer: the importance of specialist teams. Eur J Cancer 1998;34:1004-7.
3. 3 Hancock BW, Aitken M, Radstone G, et al. Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation Studies. BMJ 1997;314: 36-7.
4. 4 Cassileth BR, Zupkis V, Sutton-Smith K, et al. Information and participation preferences among cancer patients. Ann Intern Med 1980;92:832-6.
5. 5 Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
6. 6 Ward LC, Fielding JWL, Dunn JA, et al, for the British Stomach Cancer Group. The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. Br J Cancer 1992;66:943-50.
7. 7 Slevin M, Mossman J, Bowling A, et al. Volunteers or victims: patients' views of randomised cancer clinical trials. Br J Cancer 1995;71:1270-4.
8. 8 Penman DT, Holland JC, Bahna GF, et al. Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol 1984;2:849-55.
9. 9 Slevin M, Stubbs L, Plant HJ, et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990;300:1458-60.
10. 10 Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998;317:771-5.
11. 11 Crook A, Duffy A, Girling DJ, et al. Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales. Eur Respir J 1997;10:1552-8.
12. 12 Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomised clinical trial of surgery for breast cancer. N Engl J Med 1984;310:1363-7.
13. 13 Jack WJL, Chetty U, Rodger A. Recruitment to a prospective breast conservation trial: why are so few patients randomised? BMJ 1990;301:83-5.
14. 14 Smyth JF, Mossman J, Hall R, et al on behalf of the United Kingdom Co-ordinating Committee on Cancer Research. Conducting clinical research in the new NHS: the model of cancer. BMJ 1994;309:457-61.